Share Facebook Twitter LinkedIn Pinterest Email Optogenetically activating underactive VIP inhibitory neurons in the motor cortex completely restores normal circuit activity and motor learning in Huntington’s disease models, with therapeutic benefits persisting long after stimulation ends.